宗成利 教授

Chengli Zong is a Professor at the School of Pharmaceutical Sciences, Hainan University, and former Senior Scientist in the Vaccine Research Division at Merck & Co. Director of the “Advanced Vaccine Research Joint Laboratory” of Hainan University and MaxVax Biotechnology Co., Ltd., and the “Innovation Team for Carbohydrate Small-Molecule Drugs and Polysaccharide Vaccines” at Hainan University. His research focuses on carbohydrate chemistry and glycovaccine development, with multiple projects funded by the National Natural Science Foundation of China and the Hainan Provincial Natural Science Foundation. His research has been published in leading journals such as Chemical Reviews, Journal of the American Chemical Society (JACS), and Angewandte Chemie.（海南大学药学院教授，曾任默克公司疫苗研究部高级科学家。他同时担任海南大学与MaxVax生物技术有限公司“高级疫苗研究联合实验室”主任，以及海南大学“碳水化合物小分子药物与多糖疫苗创新团队”负责人。他的研究方向为碳水化合物化学和糖疫苗开发，多项研究项目获得中国国家自然科学基金和海南省自然科学基金资助。他的研究成果已在《化学评论》、《美国化学会志》（JACS）和《德国应用化学》等顶尖期刊上发表。)